Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 906019, 6 pages
http://dx.doi.org/10.1155/2014/906019
Clinical Study

The Effects of Vitamin E and Omega-3 PUFAs on Endothelial Function among Adolescents with Metabolic Syndrome

1Preventive Pediatric Cardiology Department, Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
2Metabolic Syndrome Department, Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
3Isfahan University of Medical Sciences, Isfahan, Iran
4Endocrine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Received 21 February 2014; Accepted 20 June 2014; Published 20 July 2014

Academic Editor: Luca Miele

Copyright © 2014 Alireza Ahmadi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Libby, P. M. Ridker, and A. Maseri, “Inflammation and atherosclerosis,” Circulation, vol. 105, no. 9, pp. 1135–1143, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. R. T. Lee, C. Yamamoto, Y. Feng et al., “Mechanical strain induces specific changes in the synthesis and organization of proteoglycans by vascular smooth muscle cells,” Journal of Biological Chemistry, vol. 276, no. 17, pp. 13847–13851, 2001. View at Google Scholar · View at Scopus
  3. A. Fornoni and L. Raij, “Metabolic syndrome and endothelial dysfunction,” Current Hypertension Reports, vol. 7, no. 2, pp. 88–95, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Tziomalos, V. G. Athyros, A. Karagiannis, and D. P. Mikhailidis, “Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 20, no. 2, pp. 140–146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J. A. Vita and J. F. Keaney Jr., “Endothelial function: a barometer for cardiovascular risk?” Circulation, vol. 106, no. 6, pp. 640–642, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. M. A. Creager, T. F. Lüscher, F. Cosentino, and J. A. Beckman, “Diabetes and vascular disease. Pathophysiology, clinical consequences, and medical therapy: Part I,” Circulation, vol. 108, no. 12, pp. 1527–1532, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. P. C. Deedwania, “Metabolic syndrome and vascular disease: is nature or nurture leading the new epidemic of cardiovascular disease?” Circulation, vol. 109, no. 1, pp. 2–4, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Cozma, O. Orăşan, D. Sâmpelean et al., “Endothelial dysfunction in metabolic syndrome,” Romanian Journal of Internal Medicine, vol. 47, no. 2, pp. 133–140, 2009. View at Google Scholar · View at Scopus
  9. W. A. Hsueh, C. J. Lyon, and M. J. Quiñones, “Insulin resistance and the endothelium,” The American Journal of Medicine, vol. 117, no. 2, pp. 109–117, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. J. F. Keaney Jr., D. I. Simon, and J. E. Freedman, “Vitamin E and vascular homeostasis: implications for atherosclerosis,” FASEB Journal, vol. 13, no. 9, pp. 965–976, 1999. View at Google Scholar · View at Scopus
  11. T. Heitzer, S. Ylä Herttuala, E. Wild, J. Luoma, and H. Drexler, “Effect of Vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both,” Journal of the American College of Cardiology, vol. 33, no. 2, pp. 499–505, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. U. N. Das, “Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how?” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 63, no. 6, pp. 351–362, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. P. C. Calder, “n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored,” Clinical Science, vol. 107, no. 1, pp. 1–11, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. T. A. Mori, R. J. Woodman, V. Burke, I. B. Puddey, K. D. Croft, and L. J. Beilin, “Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects,” Free Radical Biology and Medicine, vol. 35, no. 7, pp. 772–781, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Weiss, J. Dziura, T. S. Burgert et al., “Obesity and the metabolic syndrome in children and adolescents,” New England Journal of Medicine, vol. 350, no. 23, pp. 2362–2374, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. G. K. Goode, S. Garcia, and A. M. Heagerty, “Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients: a double-blind placebo-controlled study,” Circulation, vol. 96, no. 9, pp. 2802–2807, 1997. View at Google Scholar · View at Scopus
  17. H. Tagawa, H. Shimokawa, T. Tagawa, M. Kuroiwa-Matsumoto, Y. Hirooka, and A. Takeshita, “Long-term treatment with eicosapentaenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilatation in patients with coronary artery disease,” Journal of Cardiovascular Pharmacology, vol. 33, no. 4, pp. 633–640, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. M. M. Engler, M. B. Engler, M. Malloy et al., “Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the early study,” International Journal of Clinical Pharmacology and Therapeutics, vol. 42, no. 12, pp. 672–679, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. G. E. McVeigh, G. M. Brennan, G. D. Johnston et al., “Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus,” Diabetologia, vol. 36, no. 1, pp. 33–38, 1993. View at Publisher · View at Google Scholar · View at Scopus
  20. G. G. Cappellari, P. Losurdo, S. Mazzucco et al., “Treatment with n-3 polyunsaturated fatty acids reverses endothelial dysfunction and oxidative stress in experimental menopause,” Journal of Nutritional Biochemistry, vol. 24, no. 1, pp. 371–379, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. Wang, X. Liang, L. Wang et al., “Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials,” Atherosclerosis, vol. 221, no. 2, pp. 536–543, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Kliche and J. Waltenberger, “VEGF receptor signaling and endothelial function,” IUBMB Life, vol. 52, no. 1-2, pp. 61–66, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Kowalski, D. Sliwczyńska-Rodziewicz, E. Kowalczyk et al., “Plasma nitric oxide and vascular endothelial growth factor levels in patients with metabolic syndrome and co-existing vascular complications,” Polski Merkuriusz Lekarski, vol. 30, no. 178, pp. 249–252, 2011. View at Google Scholar
  24. S. Jesmin, S. Akter, M. M. Rahman et al., “Disruption of components of vascular endothelial growth factor angiogenic signalling system in metabolic syndrome. Findings from a study conducted in rural Bangladeshi women,” Thrombosis and Haemostasis, vol. 109, no. 4, pp. 696–705, 2013. View at Google Scholar
  25. C. E. Hagberg, A. Mehlem, A. Falkevall et al., “Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes,” Nature, vol. 490, no. 7420, pp. 426–430, 2012. View at Publisher · View at Google Scholar